AAAAAA

   
Results: 1-14 |
Results: 14
Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy
Authors: Duong, M Petit, JM Piroth, L Grappin, M Buisson, M Chavanet, P Hillon, S Portier, H
Citation: M. Duong et al., Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy, J ACQ IMM D, 27(3), 2001, pp. 245-250
Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response
Authors: Duong, M Piroth, L Peytavin, G Forte, F Kohli, E Grappin, M Buisson, M Chavanet, P Portier, H
Citation: M. Duong et al., Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response, CLIN INF D, 33(3), 2001, pp. 386-392
Pharmaco-economic evaluation of the use of rapid diagnostic test of adult angina
Authors: Portier, H Peyramond, D Boucot, I Pribil, C Grappin, M Chicoye, A
Citation: H. Portier et al., Pharmaco-economic evaluation of the use of rapid diagnostic test of adult angina, MED MAL INF, 31(7-8), 2001, pp. 506-507
Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review
Authors: Duong, M Buisson, M Cottin, Y Piroth, L Lhuillier, I Grappin, M Chavanet, P Wolff, JE Portier, H
Citation: M. Duong et al., Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review, CLIN CARD, 24(10), 2001, pp. 690-694
Incidence of gynecomastia in men infected with HIV and treated with highlyactive antiretroviral therapy
Authors: Piroth, L Grappin, M Petit, JM Buisson, M Duong, M Chavanet, P Portier, H
Citation: L. Piroth et al., Incidence of gynecomastia in men infected with HIV and treated with highlyactive antiretroviral therapy, SC J IN DIS, 33(7), 2001, pp. 559-560
Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice
Authors: Grappin, M Piroth, L Kohli, E Buisson, M Duong, M Chavanet, P Portier, H
Citation: M. Grappin et al., Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice, J ACQ IMM D, 25(5), 2000, pp. 464-465
Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy
Authors: Piroth, L Grappin, M Buisson, M Duong, M Portier, H Chavanet, P
Citation: L. Piroth et al., Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy, J ACQ IMM D, 23(4), 2000, pp. 356-357
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients
Authors: Piroth, L Grappin, M Cuzin, L Mouton, Y Bouchard, O Raffi, F Rey, D Peyramond, D Gourdon, F Drobacheff, C Lombart, ML Lucht, F Besnier, JM Bernard, L Chavanet, P Portier, H
Citation: L. Piroth et al., Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients, J VIRAL HEP, 7(4), 2000, pp. 302-308
Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient
Authors: Piroth, L Grappin, M Sgro, C Buisson, M Duong, M Chavanet, P
Citation: L. Piroth et al., Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient, ANN PHARMAC, 34(4), 2000, pp. 534-535
Increased prevalence of subclinical hypothyroidism in HIV patients treatedwith highly active antiretroviral therapy
Authors: Grappin, M Piroth, L Verges, B Sgro, C Mack, G Buisson, M Duong, M Chavanet, P Portier, H
Citation: M. Grappin et al., Increased prevalence of subclinical hypothyroidism in HIV patients treatedwith highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1070-1072
HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: A longitudinal study
Authors: Petit, JM Duong, M Duvillard, L Piroth, L Grappin, M Verges, B Chavanet, P Brun, JM Portier, H
Citation: Jm. Petit et al., HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: A longitudinal study, HORMONE MET, 32(9), 2000, pp. 367-372
Discontinuation of protease inhibitors due to intolerance: a longitudinal study in 309 HIV-1 positive patients
Authors: Piroth, L Grappin, M Waldner, A Sgro, C Duong, M Buisson, M Chavanet, P Portier, H
Citation: L. Piroth et al., Discontinuation of protease inhibitors due to intolerance: a longitudinal study in 309 HIV-1 positive patients, PRESSE MED, 28(8), 1999, pp. 381-387
Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients
Authors: Piroth, L Bourgeois, C Dantin, S Waldner, A Grappin, M Portier, H Chavanet, P
Citation: L. Piroth et al., Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients, AIDS, 13(4), 1999, pp. 523-524
The 1997 mortality rate in HIV-infected patients presenting cirrhosis due to hepatitis C virus. Results of the GERMIVIC multicenter survey conducted in the French departments of either internal medicine or infectious diseases
Authors: Geffray, L Rosenthal, E Cacoub, P Perronne, C Veyssier, P Raguin, G Cevallos, R Patey, O Bouchard, O Loury, I Delarocque, E Goujard, C Estavoyer, JM Dupont, C Grappin, M Morand, P Laurichesse, H Vuitton, D
Citation: L. Geffray et al., The 1997 mortality rate in HIV-infected patients presenting cirrhosis due to hepatitis C virus. Results of the GERMIVIC multicenter survey conducted in the French departments of either internal medicine or infectious diseases, REV MED IN, 20(12), 1999, pp. 1082-1087
Risultati: 1-14 |